Clinical trial · Observational
CIRculating CANcer MAster-Protocol
MAster Protocol Studying the Impact of Blood Biopsy on Screening, Diagnosis, Diagnostic and Follow-up of Solid Cancer in Adult
NCT05089747CI-TRIAL-00114215CIRCAN MAPrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adult With Solid Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood sampling for biomarker analysis (microRNA, circulating DNA…) | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Adult with solid cancer. No intervention.
- interventionNames
- Biological: Blood sampling for biomarker analysis (microRNA, circulating DNA…)
Primary outcomes (3)
- measure
- Liquid biopsy analyses
- timeFrame
- Day 0
- description
- Extraction of circulating DNA or circulating RNA followed by a tumoral cells extraction.
- measure
- Standard technics of disease assessment
- timeFrame
- Week 16
- description
- Genetic and transcriptomic explorations with immunofluorescence technique. Marking with specific markers of the tumor pathology. And enumaration of tumoral cells.
- measure
- Correlation between outcome 1 and outcome 2
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult (\>18y) * Owing a social security insurance * Any solid cancer diagnosed by histopathology or cytology * Patient with blood sampling required as per standard of care * Informed consent signed Exclusion Criteria: * Refusal to participate * No blood sampling required as per standard of care * Hemoglobin \< 7g/dl (\< 9g/dl if respiratory or cardiovascular disease history) * Heterologous blood transfusion in the last 48 hours * Weight under 20 kg
References
Publications (0)
Data not yet available
No reference posted for this study.